Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada
Paul J. Joudrey(University of Pittsburgh), E. Jennifer Edelman(Yale University), Wassim Mekideche(Université de Montréal), R. O. Olivier You Kheang(Université de Montréal), Melinda Wang(University of California, San Francisco), Jessica A. Chaiton(University of British Columbia), Ashley Medley(Yale University), Minhee Sung(Yale University), Sarah Van Buren(Yale University), Maxime Paquet(Université de Montréal), Mary Elizabeth Guerra(Yale University), Simeon D. Kimmel(Boston University), Brynna Gleeson(Vassar College), Lucy Ehrenfeld(Yale University), Jingxian Zhang(Chinese Academy of Sciences), Paxton Bach(University of British Columbia), Zoe Adams(Yale University), Emily A. Wang(Yale University)
Cited by 83
Related Papers
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
|Journal of General Internal Medicine|2019|150
Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
|The Journal of Immunology|2009|148
<i>Cryptococcus gattii</i>Dispersal Mechanisms, British Columbia, Canada
|Emerging infectious diseases|2007|146
Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study
|Drug and Alcohol Dependence|2020|119